These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 30642367)

  • 1. Omalizumab in children with severe allergic disease: a case series.
    Crisafulli G; Caminiti L; Chiera F; Arasi S; Salzano G; Panasiti I; Barbalace A; Pajno GB
    Ital J Pediatr; 2019 Jan; 45(1):13. PubMed ID: 30642367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining anti-IgE with oral immunotherapy.
    Lin C; Lee IT; Sampath V; Dinakar C; DeKruyff RH; Schneider LC; Nadeau KC
    Pediatr Allergy Immunol; 2017 Nov; 28(7):619-627. PubMed ID: 28782296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of omalizumab in patients with food allergy.
    Rafi A; Do LT; Katz R; Sheinkopf LE; Simons CW; Klaustermeyer W
    Allergy Asthma Proc; 2010; 31(1):76-83. PubMed ID: 20167148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IgE--emerging opportunities for Omalizumab.
    Babu KS; Polosa R; Morjaria JB
    Expert Opin Biol Ther; 2013 May; 13(5):765-77. PubMed ID: 23517576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of omalizumab in allergen immunotherapy.
    Dantzer JA; Wood RA
    Clin Exp Allergy; 2018 Mar; 48(3):232-240. PubMed ID: 29315922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of omalizumab in the treatment of food allergy and anaphylaxis.
    Lieberman JA; Chehade M
    Curr Allergy Asthma Rep; 2013 Feb; 13(1):78-84. PubMed ID: 23065311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy.
    Guilleminault L; Michelet M; Reber LL
    Clin Rev Allergy Immunol; 2022 Feb; 62(1):216-231. PubMed ID: 34550555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.
    Humbert M; Bousquet J; Bachert C; Palomares O; Pfister P; Kottakis I; Jaumont X; Thomsen SF; Papadopoulos NG
    J Allergy Clin Immunol Pract; 2019; 7(5):1418-1429. PubMed ID: 30928481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of anti-IgE therapy beyond allergic asthma.
    Stokes JR; Casale TB
    J Allergy Clin Immunol Pract; 2015; 3(2):162-6. PubMed ID: 25609342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab in children.
    Licari A; Marseglia A; Caimmi S; Castagnoli R; Foiadelli T; Barberi S; Marseglia GL
    Paediatr Drugs; 2014 Dec; 16(6):491-502. PubMed ID: 25404353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
    Navinés-Ferrer A; Serrano-Candelas E; Molina-Molina GJ; Martín M
    J Immunol Res; 2016; 2016():8163803. PubMed ID: 28097159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-Label Uses of Omalizumab.
    El-Qutob D
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):84-96. PubMed ID: 26048266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience.
    Chipps BE; Lanier B; Milgrom H; Deschildre A; Hedlin G; Szefler SJ; Kattan M; Kianifard F; Ortiz B; Haselkorn T; Iqbal A; Rosén K; Trzaskoma B; Busse WW
    J Allergy Clin Immunol; 2017 May; 139(5):1431-1444. PubMed ID: 28477722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial.
    Andorf S; Purington N; Block WM; Long AJ; Tupa D; Brittain E; Rudman Spergel A; Desai M; Galli SJ; Nadeau KC; Chinthrajah RS
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):85-94. PubMed ID: 29242014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab in the treatment of eosinophilic esophagitis and food allergy.
    Rocha R; Vitor AB; Trindade E; Lima R; Tavares M; Lopes J; Dias JA
    Eur J Pediatr; 2011 Nov; 170(11):1471-4. PubMed ID: 21809010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of severe asthma and peach allergy that improved with omalizumab therapy: a case report].
    Suzuki S; Matsuura T; Kimura T; Tazaki T; Fukuda M; Homma T; Matsukura S; Kurokawa M; Adachi M
    Arerugi; 2012 Feb; 61(2):215-23. PubMed ID: 22437731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab : other indications and unanswered questions.
    Mankad VS; Burks AW
    Clin Rev Allergy Immunol; 2005 Aug; 29(1):17-30. PubMed ID: 16222081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Immunotherapy for Food Allergy.
    Wood RA
    J Investig Allergol Clin Immunol; 2017; 27(3):151-159. PubMed ID: 28102823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunotherapy and potential treatment.
    Sato S; Yanagida N; Ebisawa M
    Chem Immunol Allergy; 2015; 101():106-13. PubMed ID: 26022870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab: Anti-IgE therapy in allergy.
    Kopp MV
    Curr Allergy Asthma Rep; 2011 Apr; 11(2):101-6. PubMed ID: 21243454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.